cardiovascular
-
CSL Behring advances infusion therapy trial
Global biotherapeutics leader CSL Behring, located in King of Prussia, announced that it will proceed with a global Phase 3…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
